Search

Search Constraints

You searched for: Subject 610.5

Search Results

3777. A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant article. Issue 15 (16th April 2021)